Biogen Idec and PDL: Licensing Triumphs over Acquisition
By Business Review Editor
Pharma Deals Review: Vol 2005 Issue 63 (Table of Contents)
Published: 1 Sep-2005
DOI: 10.3833/pdr.v2005.i63.627 ISSN: 1756-7874
Section: Features
Fulltext:
Abstract
Biogen Idec's and Protein Design Labs' recent antibody licensing arrangement has helped to dispel trepidation that mergers and acquisitions are replacing licensing agreements...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS